300723 ApicHope Pharmaceutical
- 21.47
- -0.07-0.32%
ApicHope Pharmaceutical News
Poinsettia (300723.SZ) plans to pay 2.1 yuan for 10 shares to be deducted from interest on June 3
Poinsettia (300723.SZ) announced that the company's 2023 equity distribution plans: cash dividends for every 10 shares...
Ping An Securities: The terminal market resumes growth and selects varieties based on space and pattern
Ping An Securities released a research report saying that judging from changes in the scale and pattern of terminal drug use, the industry ushered in restorative growth in the post-pandemic era. Innovative drugs and varieties with high barriers and good patterns are growing faster than the overall growth rate.
Poinsettia (300723.SZ): A wholly-owned subsidiary, the first-class innovative drug APH01727 tablets were accepted for clinical trial registration
Gelonghui, May 14, 丨 Yipinhong (300723.SZ) announced that recently, the drug clinical trial application for APH01727 tablets, a class of innovative drugs independently developed by Guangzhou Yipinhong Pharmaceutical Co., Ltd. (hereinafter referred to as “Yipinhong Pharmaceutical”), a wholly-owned subsidiary of the company, was accepted by the China Drug Administration and received a “Notice of Acceptance”.
Poinsettia (300723.SZ) subsidiary obtains registration certificate for oxacipine oral suspension
Yipinhong (300723.SZ) issued an announcement. Guangzhou Yipinhong Pharmaceutical Co., Ltd., a wholly-owned subsidiary of the company, recently received...
Earnings Troubles May Signal Larger Issues for ApicHope Pharmaceutical (SZSE:300723) Shareholders
ApicHope Pharmaceutical Co., Ltd's (SZSE:300723) recent weak earnings report didn't cause a big stock movement. Our analysis suggests that along with soft profit numbers, investors should be aware of
Investors More Bullish on ApicHope Pharmaceutical (SZSE:300723) This Week as Stock Grows 4.5%, Despite Earnings Trending Downwards Over Past Five Years
It might be of some concern to shareholders to see the ApicHope Pharmaceutical Co., Ltd (SZSE:300723) share price down 12% in the last month. But that doesn't change the fact that the returns over
Poinsettia (300723.SZ) announced first-quarter results, net profit of 101 million yuan, a decrease of 9.53%
According to the Zhitong Finance App, Pinot (300723.SZ) released its report for the first quarter of 2024. The company's revenue was 623 million yuan, a year-on-year decrease of 13.01%. Net profit attributable to shareholders of listed companies was 101 million yuan, a year-on-year decrease of 9.53%. Net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 98.094 million yuan, an increase of 5.16% over the previous year. Basic earnings per share were $0.2213.
Is Now The Time To Put ApicHope Pharmaceutical (SZSE:300723) On Your Watchlist?
It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story even if these companies are loss-making. Unfortunately, these high risk investment
Poinsettia (300723.SZ): The holding subsidiary signs a “Technical Service (Outsourcing) Contract” with Boji Pharmaceuticals
On April 7, Ge Longhui (300723.SZ) announced that its holding subsidiary Guangzhou Ruianbo Pharmaceutical Technology Co., Ltd. signed a “Technical Service (Outsourcing) Contract” with Boji Pharmaceutical Technology Co., Ltd. (“Boji Pharmaceutical”). The total contract amount is RMB 69.63 million (tax included. The total amount of the contract includes the project start-up cost of 2,587 million yuan in the “Early Launch Agreement for Class 1 New Chemical Drug AR882 Capsule Phase III Clinical Trials” signed by both parties in 2023). The contract agreed that Guangzhou Ruianbo commissioned Boji Pharmaceutical to launch “AR882 capsules” to treat primary pain
Poinsettia (300723.SZ): As of March 29, 2024, the total number of shareholders of the company was 13,159
Gelonghui, April 1, 丨 Pinus (300723.SZ) said on the investor interactive platform that as of March 29, 2024, the total number of shareholders of the company was 13,159.
ApicHope Pharmaceutical Co., Ltd (SZSE:300723) Stocks Shoot Up 29% But Its P/E Still Looks Reasonable
Those holding ApicHope Pharmaceutical Co., Ltd (SZSE:300723) shares would be relieved that the share price has rebounded 29% in the last thirty days, but it needs to keep going to repair the recent da
ApicHope Pharmaceutical Co., Ltd's (SZSE:300723) 16% Gain Last Week Benefited Both Private Companies Who Own 45% as Well as Insiders
Key Insights ApicHope Pharmaceutical's significant private companies ownership suggests that the key decisions are influenced by shareholders from the larger public The top 2 shareholders own 57% of
Poinsettia (300723.SZ): A wholly-owned subsidiary obtained a registration certificate for amlodipine benzenesulfonate dry suspension
On January 26, Gelonghui (300723.SZ) announced that Guangzhou Yipinhong Pharmaceutical Co., Ltd., a wholly-owned subsidiary of the company, recently received the “Drug Registration Certificate” for amlodipine benzenesulfonate dry suspensions approved and issued by the State Drug Administration. According to the approved instructions, the indications for amlodipine benzenesulfonate dry suspension are: 1. Hypertension: This product is suitable for the treatment of high blood pressure. This product can be used alone or in combination with other antihypertensive drugs. 2. Coronary heart disease: ① Chronic stable angina pectoris. This product is suitable for symptomatic treatment of chronic stable angina pectoris, and can be used alone or with other anti-angina drugs
The Total Return for ApicHope Pharmaceutical (SZSE:300723) Investors Has Risen Faster Than Earnings Growth Over the Last Five Years
ApicHope Pharmaceutical Co., Ltd (SZSE:300723) shareholders might be concerned after seeing the share price drop 19% in the last month. But that doesn't change the fact that shareholders have recei
Poinsettia (300723.SZ): As of January 19, 2024, the total number of shareholders of the company was 9,753
On January 22, Ge Longhui (300723.SZ) said on the investor interactive platform that as of January 19, 2024, the total number of shareholders of the company was 9,753.
Poinsettia (300723.SZ): As of January 10, 2024, the total number of shareholders of the company was 9874
On January 12, Ge Longhui (300723.SZ) said on the investor interactive platform that as of January 10, 2024, the total number of shareholders of the company was 9,874.
Poinsettia (300723.SZ): Pipeline product recombinant protein nanoparticle influenza vaccine is currently in preclinical research
Gelonghui, January 8, 丨 Yipinhong (300723.SZ) said on the investor interactive platform that the company is a pharmaceutical innovation enterprise focusing on the field of children's medicine and chronic disease medicine; the company's pipeline product recombinant protein nanoparticle influenza vaccine is currently still in the pre-clinical research stage.
Do Its Financials Have Any Role To Play In Driving ApicHope Pharmaceutical Co., Ltd's (SZSE:300723) Stock Up Recently?
ApicHope Pharmaceutical (SZSE:300723) has had a great run on the share market with its stock up by a significant 12% over the last three months. Given that stock prices are usually aligned with a co
Private Companies Who Hold 45% of ApicHope Pharmaceutical Co., Ltd (SZSE:300723) Gained 5.3%, Insiders Profited as Well
Key Insights ApicHope Pharmaceutical's significant private companies ownership suggests that the key decisions are influenced by shareholders from the larger public 57% of the business is held by th
Poinsettia (300723.SZ): Arthrosi presents data from a trial study of AR882 in patients with gout stones at the annual meeting of the American Society of Rheumatology
Poinsettia (300723.SZ) announced that Arthrosi, the company's shareholding company, participated in 2023/11...
Analysis
Price Target
No Data
